Many recently designed drug delivery systems have been constructed from nano-sized components that serve as the carrier or targeting ligand for a therapeutic agent. Even though these materials have been regarded previously as inert or non-active components of dosage forms, they are now recognized as sometimes being even more important than the drug itself. Hence, it is becoming increasingly imperative that the pharmaceutically relevant properties, including identity, physicochemical characteristics, purity, solubility and toxicity, of these functional nano-excipients be fully characterized. Carbon nanotubes (CNTs) are novel nanomaterials made of carbon atoms that have wide application potential in many areas of nanomedicine. However, because of their significant potential, CNTs, as building blocks for nanomedicines, need to be characterized more fully. Studies to date indicate that both physical and chemical properties of CNTs play an important role in their interactions with cells. Therefore, a full understanding of the physical properties of CNTs, such as identity, chirality, particle size, aspect ratio, morphology and dispersion state, as well as chemical properties such as purity, defect sites and types and functional groups, will be essential to develop a full characterization panel of these versatile nanomaterials.
When a drug substance is combined with a delivery system it produces a dosage form that becomes the basis of a new drug product. Over the past 30 to 40 years, drug delivery systems have become gradually more sophisticated and smaller. In addition to the general trend in reduction of size, other parameters, such as their specificity of interaction with cells and tissues and in vivo biocompatibility, have become important parameters. Many new building blocks for novel delivery systems have emerged and continue to emerge. These building blocks are nano-sized materials ranging from soft materials such as lipids, amino acids, dendrites, and polymers, to metallic nanoparticles composed of gold, silver, iron and other metals forming quantum dots, to the various nanomaterials composed of carbon.
Pharmaceutical excipients have been used typically as non-functional building blocks for drug products. The United States Pharmacopoeia (USP) defines these excipients as "any substance other than the active drug product which has been appropriately evaluated for safety and is included in a drug delivery system to either i) aid processing of the system during manufacture or ii) protect, support or enhance stability, bioavailability, or patient acceptability or iii) assist in product identification or iv) enhance any other attribute of the overall safety and effectiveness of the drug product during storage and use." The USP has described the requirements for 550 excipients in monographs; however, many more excipients currently used in pharmaceutical products are awaiting the development of such monographs.
More recently, refinement in the understanding of functionality of excipients has also become important. The functionality-related characteristics (FCRs) for a specific excipient will be those that are relevant to the dosage form or the product being developed. The new General Information Chapter on Excipient Performance <1059> will facilitate new excipient characterization and the development of additional guidelines.
Carbon nanotubes as pharmaceutical excipients
Carbon nanotubes (CNTs) are a novel class of carbon-based nanomaterials, with potential as future excipients for dosage form and drug delivery system development [1, 2] . CNTs are cylindrical molecules consisting of a hexagonal arrangement of sp 2 -hybridized carbon atoms (C-C distance of ~1.4 Å). These hollow tubes of carbon are formed by rolling single or multiple layers of graphene sheets into seamless cylindrical structures. The most common forms of CNTs are single-walled carbon nanotubes (SWNTs) [3] and multi-walled carbon nanotubes (MWNTs) [4] . SWNTs are comprised of a single cylindrical graphene layer and MWNTs are comprised of several to tens of concentric cylinders of graphitic shells. MWNTs generally have a larger outer diameter (2.5-100 nm) than [4] , that recognition of their potential piqued the interest of the scientific community. SWNTs were also independently discovered in early 1993 by scientists at IBM's Almaden Research Center and at NEC in Japan.
CNTs have attracted wide attention because of their considerable versatility and desirable physical and chemical properties [5] [6] [7] . Depending on the direction in which the graphene sheet is rolled, the resulting CNTs may have armchair, zigzag or other chiralities, resulting in different electrical properties, where the armchair types are metallic and the zigzag types are semiconducting. Nanotubes, whether single-, double-, or multi-walled, have high aspect ratios, with diameters typically in the range of 1-20 nm and lengths up to several mm. Other characteristics include ultra-light weight, high thermal conductivity, and unusual mechanical and electronic properties. Each CNT can be considered a single macromolecule formed from a number of carbon atoms in a specific structure. CNTs are produced as powders or as solid aligned tubes on a substrate from which they are scraped off to form a bulk black powder. The appearance of the CNT powder depends on the process used to synthesize them, as well as on the type of nanotubes. Table 1 shows four different types of CNT bulk materials, ranging from a light fluffy powder to a dense granular material. The physicochemical parameters shown are those provided by their respective manufacturers. The corresponding high-resolution transmission electron microscopic (TEM) images were obtained by dispersing the respective nanotubes in 1,2-dichlorobenzene and viewing them on holey 300-mesh grids using a JEOL 2010F electron microscope (detailed study in manuscript in preparation).
Individual, pristine carbon fibers can become entangled with other fibers, creating ropes that are difficult to disperse. Entanglement is particularly important to overcome, as dispersion or solubilization of CNTs in aqueous solutions is necessary for their application as drug delivery systems.
Generally, pharmaceutically relevant properties of CNTs may include molecular state such as size, type, aspect ratio, and the presence and type of functional groups (Table 2) . Full pharmaceutical characterization of CNTs will require a set of relevant assays that reflect the desired properties for human applications. 
Carbon nanotubes as building blocks for drug delivery systems
The versatility of CNTs can be controlled and optimized for bionanotechnological use in many ways (Fig. 2) . Generally, both unfunctionalized and functionalized nanotubes may be employed to design delivery systems. Analysis of available data can be used to determine which properties of CNTs are particularly important to control in order to achieve both safety and efficacy, to what degree can general requirements be imposed and which will be specific properties that will need to be evaluated case-by-case.
C T size, type and structure-related properties
To evaluate CNTs for drug delivery potential and biocompatibility, the first parameter of interest usually is particle size. Both length and diameter of nanotubes appear to be critical for function and avoidance of adverse effects [8] . Strano et al. [9, 10] Biodistribution studies of 125 I-labelled SWNTs (1.5 µg dose in 100 µL; 300 nm long and 1.4 nm diameter) in mice after intraperitoneal, intravenous, subcutaneous or oral gavage administration indicated that these nanotubes were distributed to all organs similarly as small molecules are typically distributed [11] . The brain was the only exception, where minimal uptake was seen in all cases.
Excretion was mainly through urine. This biodistribution and excretion pattern was confirmed by 56 Advanced Bioceramics in Nanomedicine and Tissue Engineering others [12, 13] . SWNTs and MWNTs functionalized with the chelating molecule diethylentriaminepentaacetic (DTPA) and labeled with 111 In was evaluated in mice after IV injection [12] . The main excretion pathway was through the kidneys in the urine and no accumulation in the liver was observed. Clearance from the blood was rapid, with a t½ =3 h. Lacerda et al. [13] Nanotube defects may also be common in CNT raw materials. During purification of CNTs, strong acid treatment oxidative reactions form carboxyl residues at the ends or at the sides of the nanotubes.
Defects may vary from loss or addition of a carbon atom, creating a vacancy or a double coordinated atom and resulting in the formation of five-or seven-membered carbon rings [16, 17] . The five-or seven-membered rings in the carbon framework, instead of the normal six-membered ring, may lead to a bend in the tube, and the carbon framework damaged by oxidative conditions may create a hole lined with COOH groups. The combination of two five-and two seven-membered rings is called the StoneWales (7-5-5-7) defect on the sidewall of a nanotube [16] and covalent bonds between the layers of a MWNT [18] may also form. It is not clear, however, whether the presence or the extent of defects on the nanotubes has an effect on their biological function or toxicity.
3.2.Carbonaceous and non-carbonaceous impurities, solvent residues
CNT samples contain two categories of impurities: metallic catalytic impurities used for in the synthesis of CNTs, and carbonaceous impurities. Typically, CNTs purchased from vendors are accompanied by product information sheets containing quality analysis of the accompanying material.
Some vendors provide very limited information in the form of a Raman spectrum and/or an electron micrograph (either by SEM or TEM) and elemental analysis for metal content. Others provide more extensive information (see Table 1 ). The assignment of >90% or greater purity may mean that the sample contains >90% carbonaceous content but not necessarily >90% nanotube content. Poland et al.
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Most nanotube raw materials produced by the chemical vapour deposition (CVD) synthetic process contains metallic impurities; therefore, it is difficult to show lack of toxicity of CNTs synthesized by this method. Miyawaki et al [19] conducted a toxicity study using single-wall carbon nanohorns (SWNH), a cone-shaped type of carbon nanomaterial (see Fig. 1 ) produced by laser ablation, a synthesis method that does not result in contamination with undesirable metal impurities.
Here, the SWNHs were shown to be non-toxic in a panel of rigorous tests, including Ames test, chromosomal aberration test, skin primary irritation and eye irritation tests, and acute peroral and intratracheal toxicity test. They also found no mutagenic, clastogenic or carcinogenic effects. The lethal oral dose in rats was greater than 2000 mg/kg, and very limited lung tissue damage was seen.
Porter et al. [20] used SWNTs (0.9-1.2 nm diameter, CVD-HiPCO process) dispersed in tetrahydrofuran (THF) for incubation with human monocyte-derived macrophages at 0-10 µg/mL.
CNTs were located in the lysosomes and then in the nuclei by day 2. By day 4 apoptosis and necrosis of cells were noticeable at 5 µg/mL CNT concentration. CNT cellular uptake was by phagocytosis and by crossing the cellular and nuclear membranes by passive diffusion. The nanotube dispersion in THF was reported to contain iron catalyst particles and onion-like structures (graphitic carbon), all of which, including the solvent, could have contributed to cellular toxicity. In a subsequent study the same authors showed that with acid-purified SWNTs dispersed in aqueous media no significant changes were observed in cell viability or structure even after 4 days of exposure [21] . Additionally, purified SWNTs were less aggregated within cells compared with unpurified SWNTs, although both bundles and individual acid-treated SWNTs could be found inside lysosomes and the cytoplasm.
The presence of metals in CNTs may contribute to oxidative stress and significant toxicity. In early studies toxic effects attributed to CNTs were in fact due to the presence of metallic impurities [22, 23] . However, the extent of effect of metallic residues is still unclear. In a recent comparative study high purity MWNTs (less than 0.0005% Fe) were more toxic to human macrophages than the Fe 2 O 3 catalyst itself [24] .
The importance of the availability of detailed and accurate information on the CNT raw materials is key to understanding the toxic effects of nanotubes and is strongly recognized in the field as data essential for their characterization and development as nano-excipients. [25] [26] [27] .
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C T surface properties
CNTs lend themselves to a range of chemical modifications [28] [29] [30] [31] . Both covalent and non-covalent functionalizations are possible at intact CNT sidewalls, at defect sites on sidewalls or at the tip of the nanotubes. The most common modification is the formation of carboxyl residues upon strong acid treatment, followed by esterification or amidization of carboxyl groups and the 1,3-dipolar cycloaddition of azomethine ylides [7] . The presence of PEG (PEG 5400 provided longer circulation time than PEG2000; t½ = 2 h vs 0.5 h)
was important for stealth function and the RGD peptide was important for targeting.
SWNTs conjugated to epidermal growth factor (EGF) and cisplatin selectively killed head and neck squamous carcinoma cells that were overexpressing EGF receptors [38] . SWNTs (0.5 mg/mL, made by HiPCO process by Carbon Nanotech) were oxidized by acid treatment and the resulting carboxyl groups were functionalized with EGF and Quantum dots using EDC chemistry. The final concentration used was 0.25 mg/mL SWNT with 1.3 µM bound cisplatin. Analysis indicated the presence of 36 EGF molecules per 100 nm length of nanotube. The nanotubes were short, 110±50 nm estimated from electron microscopic images, and the diameter was 10 nm, indicative of small bundles rather than individual SWNTs [38] .
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In the case of functionalized nanotubes, the nature of the functional groups on the nanotubes influences the interaction between nanotubes and cells. [36] . There are potentially three cellular uptake mechanisms that may govern CNT internalization into cells: energy-dependent endocytotic and energy -independent diffusion and bidirectional uptake processes, however, it is not clear what combination of nanotube characteristics are the most important in each case. Further studies will be needed to better understand overall CNT structure/function versus uptake mechanism relationships
Dispersibility
The solubilization of pristine CNTs in aqueous solvents is difficult because of the hydrophobicity of the graphene sidewalls and the strong π-π interactions between individual tubes.
Although unfunctionalized CNTs are typically very hydrophobic and insoluble in aqueous media, as a solid or a dispersion in a polymer matrix without the need for solubilization they have several potential applications. Venkatesan et al. [40, 41] incorporated erythropoietin (EPO) into a CNT matrix, which was measured out by weight. Intra-jejunal administration of this EPO (100U/kg)-CNTlabrasol solid dispersion increased the bioavailability of EPO. Unfortunately, the type and purity of CNTs in this study were not available. Short CNTs were two times more efficient compared with the long tubes, and serum EPO level reached a c max of 143.1+/-15.2 mIU/mL. Unfunctionalized nanotubes, in the form of CNT bundles, can also be used as a support matrix for neural cell growth.
Neurons grown on CNT bundles survive for several days and increase dendrite outgrowth [42, 43] .
Electrical coupling of SWNTs and neurons was demonstrated using NG108 and rat primary peripheral neurons [44] .
Another example using unfunctionalized nanotubes is by Cai et al. [45] who reported the use of CNTs as spears to deliver plasmid DNA encoding green fluorescent protein (EGFP) into Bal 17 Blymphoma and B cells. Vertically aligned nanotubes grown by plasma-enhanced CVD with ferromagnetic nickel particles embedded at the tips were used as carriers and were driven into cells membranes under the influence of a magnetic force. This technique resulted in high transduction efficiency and viability after transduction. [33] . The potential of magnetofection delivery includes a drastic lowering of vector dose since close to 100% of cells were reported to express EGFP protein [45] .
CNTs can also be used to create nanocomposite materials for medical device development.
Pristine CNTs mixed with Nylon-12 form a nanocomposite material that can be extruded to form microcatheters for arterial cannulation. The biocompatibility of such CNT-based microcatheters was 60 Advanced Bioceramics in Nanomedicine and Tissue Engineering greater, and less cellular infiltration and no inflammatory reaction occurred, compared with a Nylononly microcatheter [46] .
Most other applications of CNTs require dispersion, dissolution or debundling of nanotubes to individual fibers. The preparation of CNT dispersions with uniform distribution of individual nanotubes is still a significant challenge. To successfully disperse CNTs in aqueous media, the medium should be capable of both wetting the hydrophobic tube surfaces and modifying the tube surfaces to decrease tube aggregation. Generally, four approaches have been used to obtain a CNT dispersion: (1) functionalization of CNT sidewalls [47] [48] [49] [50] [51] [52] [53] [54] ; (2) surfactant-assisted dispersion [55] [56] [57] [58] [59] [60] [61] ;
(3) solvent dispersion [62, 63] ; and (4) [98] . Table 2 lists the most frequently used analytical methods to characterize various physicochemical parameters of CNTs.
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C T concentration
Many studies have indicated concentration-dependent toxicity of CNTs in cell culture [99] [100] [101] [102] However, the CNTs assessed were from different sources (with limited information on purity) and were purified and functionalized using different methods. The resulting final CNT solutions typically had no specific analysis of concentration, but probably were calculated based on the known starting amount of CNT powder. Since the starting material contains various levels of impurities and during purification significant amount of CNT aggregates may be removed, the exact concentration may be unknown. Although it is understandable that accurate concentrations may be difficult to obtain because of the lack of available CNT reference standards, this may indicate that reported values of concentrations in most papers are approximate.
UV spectroscopy is currently used by many laboratories as a simple technique to determine CNT concentration. Absorbance at selected wavelengths can be used to calculate nanotube concentration. Several authors routinely use UV absorbance at 500 nm to determine CNT concentration [67, 98, 104] . Rastogi et al. studied the effect of surfactants on the degree of dispersion of MWNTs, by monitoring absorbance at 500 nm and using ε = 28.6 cm 2 mg -1 from [67] , to calculate the concentration of solubilized CNTs. Ikeda et al. [67] , working with aqueous solutions of SWNTs, adopted the ε 500 from Bahr et al. [104] , based on the standard curve of concentration of SWNTs in 1,2-dichlorobenzene versus optical density at 500 nm. The use of one ε value for different CNTs in different solvents without a specific calibration curve, or using calibration curves prepared from same CNT dispersion for which concentration is to be determined, introduces unreliable data, and creates confusion in interpretation of different data sets.
Therefore, even though the use of UV spectroscopy would allow routine analysis of CNT concentration, the lack of CNT standard(s) makes it difficult to conduct reliable UV analyses of different types of nanotubes in different solvents. [109] used this method to sort nanotubes by electric structure. Wei et al. [110] used cosurfactant extraction to selectively enrich (6, 5) and (8, 3) nanotubes. Another strategy is the growth, also termed 'cloning', of nanotubes, with specific chiralities from 'templates' or 'seeds' with the desired chirality [111, 112] .
Selective synthesis of nanotubes with specific chiralities and narrow diameter distribution was achieved by the use of bimetallic catalysts. FeRu catalyst produced (6,5) SWNTs [113] , whereas
CoMo catalyst produced narrow (n,m) distribution when using different carbon precursors [114] .
anoparticle classifications
Recognition of the rapidly growing number of nanomaterials and nanostructures and the lack of systematic classifications has led to recent proposals on nomenclature systems and systematic naming, as well as the development of deeper relational connections of periodic properties for nanoparticles.
These recent ideas will be important for a clearer interpretation of results obtained when using nanomaterials. Gentleman and Chen [115] proposed a nomenclature system for seven categories of particles with a range of morphologies. In this system each nanoparticle system would have a code to describe its basic properties. The code would contain five typographic fields, such as the chemical indicates the diameter and the shape being elongated, 0 stand for no core, Ful, Ful indicates sheet structure and O indicates logD>1, i.e., its hydrophobic properties.
Tomalia recently proposed a systematic framework for a nanoperiodic system, in recognition of the need for predicting important risk-benefit boundaries. The system proposes extensive nanoperiodicity classifications for size, shape, surface chemistry, elemental composition, flexibility, and architecture of hard and soft nanoparticles. These so-called Critical Nanoscale Design Parameters (CNDP) [116] determine corresponding intrinsic physicochemical properties, such as viscosity, density and refractive index, leading to systematic and predictable behavior.
Summary
In the pharmaceutical field particle characterization has always been an integral part of formulation development for solid as well as dispersion dosage forms. However, nano-sized particles present new challenges, since small changes in their parameters can cause dramatic differences in properties, biocompatibility and pharmacokinetics [117] . These general considerations are applicable to CNTs as well. Evidence thus far supports the hypothesis that the size (i.e., length and diameter), solubility and surface characteristics including functional groups play a significant role in the biocompatibility and biological fate of CNTs. However, many other characteristics will also need to be determined and correlated with drug delivery functions and adverse effects.
Overall, the following is a list in two categories -i.e., individual particles and bulk material -of the most important parameters that are relevant for drug delivery and risk assessment of CNTs.
Individual particle properties include size, surface area, shape, surface charge, surface coatings, stability and structure. Bulk properties include purity, size distribution, solubility and the medium. Full characterization of these properties will provide information toward establishing CNTs as pharmaceutical excipients.
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